FDA Approved: DIURIL — Supplemental Application (Salix Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Salix's Diuril (chlorothiazide), approving changes to its labeling as part of the supplemental submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hepatic Cirrhosis
• Hypertension
• Kidney Disease

Drugs mentioned

• DIURIL (Chlorothiazide)

Snippet

SUPPL AP for DIURIL (CHLOROTHIAZIDE)